The holy grail: pan-cancer-targeting T cells

Crowther and Dolton et al. identified an unconventional human T cell clone capable of killing many different types of cancer in vitro in an HLA-independent fashion while sparing healthy cells. Using genome-wide CRISPR-Cas9 screening, the researchers showed that the T cell clone recognized the ubiquitously expressed, mostly monomorphic, MHC-I-related protein MR1 on the surface of cancer cells when MR1 was loaded with a yet unidentified cancer-specific or cancer-associated ligand. Adoptive transfer of this T cell clone into immunodeficient NSG mice with leukemia reduced tumor burden and increased survival.

Single-Cell Imaging of Metastatic Potential of Cancer Cells

Can we predict T cell specificity with digital biology and machine

Vector engineering, strategies and targets in cancer gene therapy

Pan-cancer T cell atlas links a cellular stress response state to

Cross-priming of tumor cross-reactive T cells using SLiPs isolated

The holy grail: pan-cancer-targeting T cells

Is Immunotherapy the Holy Grail for Pancreatic Cancer? - Pereira Lab

Controversial role of γδ T cells in pancreatic cancer - ScienceDirect

Cancer immunoediting and resistance to T cell-based immunotherapy

Frontiers γδ T cells as a potential therapeutic agent for

IJMS, Free Full-Text

The Quest for Cancer-Detecting Blood Tests Speeds Up

Pan-cancer T cell atlas links a cellular stress response state to

Frontiers Adoptive NK Cell Therapy - a Beacon of Hope in

Weekly Digests for February 2020

Screening for Lung Cancer — 10 States, 2017

Surgical stress and cancer progression: the twisted tango, Molecular Cancer

Targeting Tumor Stroma - Oncology & Cancer Treatment

JPM, Free Full-Text

Mon Réseau cancer colorectal Nutrition et cancer colorectal